Scarica l'app Stockscreener
4.70
4.28%
-0.21
Dopo l'orario di chiusura:
4.70
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SCYX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.91
Aprire:
$4.82
Volume 24 ore:
47,343
Relative Volume:
0.36
Capitalizzazione di mercato:
$46.76M
Reddito:
$20.34M
Utile/perdita netta:
$-24.52M
Rapporto P/E:
-1.3143
EPS:
-3.5761
Flusso di cassa netto:
$-5.92M
1 W Prestazione:
-12.07%
1M Prestazione:
-8.83%
6M Prestazione:
-34.69%
1 anno Prestazione:
-43.51%
Intervallo 1D:
$4.63
$4.97
Intervallo di 1 settimana:
$4.63
$5.45
Portata 52W:
$3.53
$10.48
Scynexis Inc Stock (SCYX) Company Profile
Nome
Scynexis Inc
Settore
Telefono
201-884-5485
Indirizzo
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Compare SCYX vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
4.70 | 48.85M | 20.34M | -24.52M | -5.92M | -3.5761 |
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 58.15B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.35 | 42.94B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.59B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.86 | 30.29B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.86 | 21.74B | 3.17B | 1.29B | 1.01B | 27.09 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-01-22 | Iniziato | Guggenheim | Buy |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-07-11 | Aggiornamento | Needham | Hold → Buy |
| 2018-06-27 | Iniziato | Maxim Group | Buy |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2017-07-10 | Iniziato | ROTH Capital | Buy |
| 2017-05-09 | Downgrade | Needham | Buy → Hold |
| 2017-03-03 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-10-20 | Iniziato | H.C. Wainwright | Buy |
| 2016-10-07 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | Ripresa | Brean Capital | Buy |
| 2016-08-17 | Iniziato | Guggenheim | Buy |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-08-09 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | Iniziato | Brean Capital | Buy |
| 2015-12-29 | Iniziato | WBB Securities | Speculative Buy |
| 2015-11-16 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-06-10 | Iniziato | Needham | Buy |
| 2014-05-29 | Iniziato | Canaccord Genuity | Buy |
| 2014-05-29 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Scynexis Inc Borsa (SCYX) Ultime notizie
Scynexis names Sanjay Subramanian as chief financial officer - Investing.com
SCYNEXIS, Inc. Announces Executive Changes, Effective September 9, 2026 - marketscreener.com
SCYNEXIS, Inc. Announces CFO Changes, Effective September 9, 2026 - marketscreener.com
SCYNEXIS Appoints Sanjay Subramanian CFO as Biotech Advances Rare Disease Pipeline - citybiz
SCYNEXIS Names Sanjay Subramanian as CFO - marketscreener.com
Scynexis names Sanjay Subramanian as chief financial officer By Investing.com - Investing.com India
Form 8K Scynexis Inc For: 10 September By Investing.com - Investing.com Canada
SCYNEXIS appoints new CFO amid leadership transition - TipRanks
Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer - TradingView
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer - marketscreener.com
A new finance chief brings 20 years of experience to SCYNEXIS - Stock Titan
SCYNEXIS Inc. (SCYX) Advances 1.92% to $5.32 as Stock Holds Above Key $5.05 SupportDiamond Pattern - vinanet.vn
Scynexis Inc (SCYX) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
SCYNEXIS, Inc. (SCYX) latest stock news and headlines - au.finance.yahoo.com
SCYNEXIS to Participate in Upcoming Investor Conferences - The Manila Times
Scynexis Inc (SCYX) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
12 Health Care Stocks Moving In Wednesday's Intraday SessionBiohaven (NYSE:BHVN), SCYNEXIS (NASDAQ:SCY - benzinga.com
SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Press Release: SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - Moomoo
SCYNEXIS (SCYX) Market: Moves 3.60% Up to $5.33; Boundary Watch: the Near-Term Reference Band Stretches From $5.06 to $5.60 under the Current SnapshotShort Setup Alerts - vinanet.vn
SCYNEXIS (NASDAQ:SCYX) Upgraded at Wall Street Zen - MarketBeat
SCYX Q1 2026 Earnings: Deep EPS Miss and Missing Revenue Put Pipeline Execution in FocusEstimate Dispersion - vinanet.vn
SCYNEXIS (SCYX) investors CVI and Heights disclose 5.9% ownership stake - Stock Titan
Revenue per share of SCYNEXIS, Inc. – DUS:135 - TradingView
Free cash flow per share of SCYNEXIS, Inc. – DUS:135 - TradingView
SCYNEXIS, Inc. Earnings and Revenue – DUS:135 - TradingView
135 Forecast — Price Target — Prediction for 2027 - TradingView
SCYNEXIS, Inc.: Fundamental Analysis and Financial Ratings | 135 | US8112923094 - marketscreener.com
Great Point Partners (SCYX) reports 9.99% beneficial stake in Scynexis - Stock Titan
Results: SCYNEXIS, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st
SCYX Maintained by Guggenheim -- Price Target Raised to $33.00 - GuruFocus
Guggenheim raises Scynexis stock price target to $33 on drug potential - Investing.com Nigeria
Adage Capital group (SCYX) discloses 1,041,824-share SCYNEXIS stake including warrants - Stock Titan
Scynexis Inc earnings beat by $1.14, revenue topped estimates - Investing.com Nigeria
Scynexis Q2 adjusted EPS misses estimate as sales decline 82.77% - scanx.trade
SCYX Looks 78.3% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Scynexis: Q2 Earnings Snapshot - AOL.com
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
SCYNEXIS (NASDAQ:SCYX) Announces Quarterly Earnings Results, Beats Expectations By $1.14 EPS - marketbeat.com
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies - TradingView
Scynexis (NASDAQ: SCYX) lifts cash and pipeline with Q2 2026 moves - Stock Titan
SCYNEXIS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
SCYNEXIS (NASDAQ:SCYX) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
SCYNEXIS Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView
SCYNEXIS Inc. R (135.MU) insider ownership and holdings - Yahoo Finance Australia
SCYNEXIS Inc (SCYX) Stock News Today - TradingKey
SCYNEXIS Inc (SCYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SCYNEXIS (SCYX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Scynexis Deadline Alert - TMX Newsfile
SCYX Q1 2026 Earnings: Wider-Than-Expected Loss of -$3.36 Per Share, Yet Stock Climbs 30.46%Segment Revenue Breakdown - vinanet.vn
Scynexis stock price target reiterated at $44.64 by Brookline - Investing.com Nigeria
Scynexis Inc Azioni (SCYX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):